Background People with pulmonary fibrosis often experience a protracted time to diagnosis,
high symptom burden and limited disease information. This review aimed to identify the …

Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and survival …

Rationale: The interstitial lung disease (ILD) multidisciplinary meetings (MDM), composed
of pulmonologists, radiologists, and pathologists, is integral to the rendering of an accurate …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrosing lung disease that
leads to unrelenting dyspnoea and chronic cough, and ultimately respiratory failure [1]. IPF is …

Background and objective: The research term “interstitial pneumonia with autoimmune
features” (IPAF) encompasses interstitial lung disease (ILD) patients with autoimmune features …

Background Many patients with interstitial lung disease (ILD) experience poor sleep quality,
which may contribute to decreased quality of life. Sleep disordered breathing is commonly …

Background and objective In Australia, little is known about delivery of care for people with
idiopathic pulmonary fibrosis (IPF). This study examined the organization of IPF care across …

The novel coronavirus pandemic continues to have a dramatic impact upon all aspects of
health care. Interstitial lung disease (ILD) clinicians and patients alike are faced with new …

Nonspecific interstitial pneumonia (NSIP) is a complex disorder commonly associated with
other conditions such as connective tissue diseases (CTDs) and environmental exposures. …

Background and objective People living with pulmonary fibrosis (PF) report unmet needs for
information and support. Lung Foundation Australia (LFA) have developed the Peer …